Huntsman Carole sold MDGL
November 21, 2025 · Form 4 insider transaction
Huntsman Carole sold 200 shares of Madrigal Pharmaceuticals, Inc. at $552.38 per share, a transaction worth $110.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$552.38
Total value
$110.5K
InsiderHuntsman Carole
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 21, 2025
Filing dateNovember 21, 2025
Shares owned after10,592
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.96 to $552.81, inclusive.